Background: Fabry disease (FD) is an X-linked lysosomal storage disorder frequently associated with cerebrovascular disease. In recent years, the prevalence of FD has been reported to be up to 4% in cryptogenic young stroke patients. However, there have been no population-based studies in unselected patients with transient ischaemic attack (TIA) or stroke across the full range of ages. Methods: We determined the prevalence of FD mutations in consecutive patients from a population-based study of acute TIA or ischaemic stroke (Oxford Vascular Study). Analysis included amplifying of the α-galactosidase A gene by polymerase chain reaction, denaturing high-performance liquid chromatography (dHPLC) analysis and sequencing using standard automated...
Background: TIA and stroke, both ischemic and hemorrhagic, may complicate Fabry disease at young-adu...
<div><p>Background and Purpose</p><p>Cerebral autosomal dominant arteriopathy with subcortical infar...
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)...
BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disorder frequently associated with ...
BACKGROUND AND PURPOSE: The etiology of stroke in young patients remains undetermined in up to half ...
Background: Fabry disease (FD) is a treatable X-linked lysosomal storage disorder caused by GLA gene...
Background: Fabry disease (FD) is known as a rare cause of stroke. Recent studies suggested that FD ...
OBJECTIVE: To assess the prevalence of Fabry disease in young patients with cryptogenic stroke. PATI...
BACKGROUND AND PURPOSE: Data on the prevalence of Fabry disease in patients with central nervous sys...
Introduction: Fabry disease (FD) is an X-linked lysosomal storage disorder characterized by a defici...
OBJECTIVE: In the Belgian Fabry Study (BeFaS), the prevalence of Fabry disease was assessed in 1000 ...
OBJECTIVE: In the Belgian Fabry Study (BeFaS), the prevalence of Fabry disease was assessed in 1000 ...
Objective: In the Belgian Fabry Study (BeFaS), the prevalence of Fabry disease was assessed in 1000 ...
Background and Purpose—Data on the prevalence of Fabry disease in patients with central nervous syst...
BACKGROUND AND PURPOSE: Data on the prevalence of Fabry disease in patients with central nervous sys...
Background: TIA and stroke, both ischemic and hemorrhagic, may complicate Fabry disease at young-adu...
<div><p>Background and Purpose</p><p>Cerebral autosomal dominant arteriopathy with subcortical infar...
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)...
BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disorder frequently associated with ...
BACKGROUND AND PURPOSE: The etiology of stroke in young patients remains undetermined in up to half ...
Background: Fabry disease (FD) is a treatable X-linked lysosomal storage disorder caused by GLA gene...
Background: Fabry disease (FD) is known as a rare cause of stroke. Recent studies suggested that FD ...
OBJECTIVE: To assess the prevalence of Fabry disease in young patients with cryptogenic stroke. PATI...
BACKGROUND AND PURPOSE: Data on the prevalence of Fabry disease in patients with central nervous sys...
Introduction: Fabry disease (FD) is an X-linked lysosomal storage disorder characterized by a defici...
OBJECTIVE: In the Belgian Fabry Study (BeFaS), the prevalence of Fabry disease was assessed in 1000 ...
OBJECTIVE: In the Belgian Fabry Study (BeFaS), the prevalence of Fabry disease was assessed in 1000 ...
Objective: In the Belgian Fabry Study (BeFaS), the prevalence of Fabry disease was assessed in 1000 ...
Background and Purpose—Data on the prevalence of Fabry disease in patients with central nervous syst...
BACKGROUND AND PURPOSE: Data on the prevalence of Fabry disease in patients with central nervous sys...
Background: TIA and stroke, both ischemic and hemorrhagic, may complicate Fabry disease at young-adu...
<div><p>Background and Purpose</p><p>Cerebral autosomal dominant arteriopathy with subcortical infar...
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)...